LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
LB PHARMACEUTICALS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$38.81+2.07 (+5.63%)
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Lb Pharmaceuticals has not reported a dividend
No dividend per share appears in Lb Pharmaceuticals's annual filings since fiscal 2023.